The trademark application OCUS INNOVATION LIMITED was filed by OCUS INNOVATION LIMITED, a corporation established under the laws of the British Virgin Islands (the "Applicant"). The application was published for oppositions on April 20, 2022, and it was registered by office on July 28, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals, medical and veterinary preparations
Sanitary preparations for medical purposes
Dietetic food and substances adapted for medical or veterinary use, food for babies
Dietary supplements for human beings and animals
Plasters, materials for dressings
Material for stopping teeth, dental wax
Disinfectants
Preparations for destroying vermin
Fungicides, herbicides.
The mark was filed in class 35 with following description of goods:
Retailing, wholesaling, advertising, promotion and distributorship of pharmaceutical goods, health care goods, traditional Chinese medicines, chemicals, flour, animal feed, electrical systems and industrial machinery
Professional business consultation for pharmaceutical companies
Compilation and provision of business statistical information relevant to the pharmaceutical industry
Business research on pharmaceutical goods, health care goods, traditional Chinese medicines, chemicals, flour, animal feed, electrical systems and industrial machinery
Cooperative advertising and marketing of pharmaceutical goods, health care goods, traditional Chinese medicines, chemicals, flour, animal feed, electrical systems and industrial machinery of others
Providing professional business consultation for pharmaceutical companies, including online and via telecommunications
Providing statements encapsulating and analyzing sales of pharmaceutical products
Providing business information relating to pharmaceutical goods and the pharmaceutical sector
Providing business statistical information relating to pharmaceutical goods and the pharmaceutical sector.